Literature DB >> 36229601

Activation of TRPV1 receptor facilitates myelin repair following demyelination via the regulation of microglial function.

Jing-Xian Sun1, Ke-Ying Zhu2, Yu-Meng Wang1, Dan-Jie Wang1, Mi-Zhen Zhang1, Heela Sarlus2, Irene Benito-Cuesta2, Xiao-Qiang Zhao1, Zao-Feng Zou1,3, Qing-Yang Zhong1, Yi Feng1, Shuai Wu4, Yan-Qing Wang1, Robert A Harris5, Jun Wang6.   

Abstract

The transient receptor potential vanilloid 1 (TRPV1) is a non-selective cation channel that is activated by capsaicin (CAP), the main component of chili pepper. Despite studies in several neurological diseases, the role of TRPV1 in demyelinating diseases remains unknown. Herein, we reported that TRPV1 expression was increased within the corpus callosum during demyelination in a cuprizone (CPZ)-induced demyelination mouse model. TRPV1 deficiency exacerbated motor coordinative dysfunction and demyelination in CPZ-treated mice, whereas the TRPV1 agonist CAP improved the behavioral performance and facilitated remyelination. TRPV1 was predominantly expressed in Iba1+ microglia/macrophages in human brain sections of multiple sclerosis patients and mouse corpus callosum under demyelinating conditions. TRPV1 deficiency decreased microglial recruitment to the corpus callosum, with an associated increase in the accumulation of myelin debris. Conversely, the activation of TRPV1 by CAP enhanced the recruitment of microglia to the corpus callosum and potentiated myelin debris clearance. Using real-time live imaging we confirmed an increased phagocytic function of microglia following CAP treatment. In addition, the expression of the scavenger receptor CD36 was increased, and that of the glycolysis regulators Hif1a and Hk2 was decreased. We conclude that TRPV1 is an important regulator of microglial function in the context of demyelination and may serve as a promising therapeutic target for demyelinating diseases such as multiple sclerosis.
© 2022. The Author(s), under exclusive licence to Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Chinese Pharmacological Society.

Entities:  

Keywords:  TRPV1; capsaicin; microglia; phagocytosis; remyelination

Year:  2022        PMID: 36229601     DOI: 10.1038/s41401-022-01000-7

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   7.169


  62 in total

1.  The capsaicin receptor: a heat-activated ion channel in the pain pathway.

Authors:  M J Caterina; M A Schumacher; M Tominaga; T A Rosen; J D Levine; D Julius
Journal:  Nature       Date:  1997-10-23       Impact factor: 49.962

Review 2.  Transient receptor potential channels as therapeutic targets.

Authors:  Magdalene M Moran; Michael Allen McAlexander; Tamás Bíró; Arpad Szallasi
Journal:  Nat Rev Drug Discov       Date:  2011-08-01       Impact factor: 84.694

Review 3.  Myelin in the Central Nervous System: Structure, Function, and Pathology.

Authors:  Christine Stadelmann; Sebastian Timmler; Alonso Barrantes-Freer; Mikael Simons
Journal:  Physiol Rev       Date:  2019-07-01       Impact factor: 37.312

Review 4.  Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis.

Authors:  Tomas Olsson; Lisa F Barcellos; Lars Alfredsson
Journal:  Nat Rev Neurol       Date:  2016-12-09       Impact factor: 42.937

Review 5.  Microglia in Central Nervous System Inflammation and Multiple Sclerosis Pathology.

Authors:  Sofie Voet; Marco Prinz; Geert van Loo
Journal:  Trends Mol Med       Date:  2018-12-18       Impact factor: 11.951

Review 6.  Microglia Biology: One Century of Evolving Concepts.

Authors:  Marco Prinz; Steffen Jung; Josef Priller
Journal:  Cell       Date:  2019-10-03       Impact factor: 41.582

Review 7.  Multiple Sclerosis.

Authors:  Daniel S Reich; Claudia F Lucchinetti; Peter A Calabresi
Journal:  N Engl J Med       Date:  2018-01-11       Impact factor: 91.245

Review 8.  Progressive multiple sclerosis: from pathophysiology to therapeutic strategies.

Authors:  Simon Faissner; Jason R Plemel; Ralf Gold; V Wee Yong
Journal:  Nat Rev Drug Discov       Date:  2019-08-09       Impact factor: 84.694

Review 9.  Regenerating CNS myelin - from mechanisms to experimental medicines.

Authors:  Robin J M Franklin; Charles Ffrench-Constant
Journal:  Nat Rev Neurosci       Date:  2017-11-16       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.